BioLife Solutions, Inc.

NasdaqCM:BLFS Rapport sur les actions

Capitalisation boursière : US$1.2b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

BioLife Solutions Gestion

Gestion contrôle des critères 2/4

Le PDG BioLife Solutions' est Rod de Greef, nommé en Oct2023, a un mandat de moins d'un an. La rémunération annuelle totale est $ 6.39M, composée du salaire de 3.1% et des bonus 96.9%, y compris les actions et options de la société. détient directement 0.15% des actions de la société, d'une valeur de $ 1.77M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 2.8 ans et 15.8 ans.

Informations clés

Rod de Greef

Directeur général

US$6.4m

Rémunération totale

Pourcentage du salaire du PDG3.1%
Durée du mandat du directeur généralless than a year
Propriété du PDG0.1%
Durée moyenne d'occupation des postes de direction2.8yrs
Durée moyenne du mandat des membres du conseil d'administration15.8yrs

Mises à jour récentes de la gestion

Recent updates

Investors Appear Satisfied With BioLife Solutions, Inc.'s (NASDAQ:BLFS) Prospects As Shares Rocket 28%

Aug 14
Investors Appear Satisfied With BioLife Solutions, Inc.'s (NASDAQ:BLFS) Prospects As Shares Rocket 28%

BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

Jun 20
BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

A Look At The Fair Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)

Jun 05
A Look At The Fair Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)

Revenues Not Telling The Story For BioLife Solutions, Inc. (NASDAQ:BLFS) After Shares Rise 25%

May 14
Revenues Not Telling The Story For BioLife Solutions, Inc. (NASDAQ:BLFS) After Shares Rise 25%

Broker Revenue Forecasts For BioLife Solutions, Inc. (NASDAQ:BLFS) Are Surging Higher

May 13
Broker Revenue Forecasts For BioLife Solutions, Inc. (NASDAQ:BLFS) Are Surging Higher

Should You Investigate BioLife Solutions, Inc. (NASDAQ:BLFS) At US$19.54?

May 11
Should You Investigate BioLife Solutions, Inc. (NASDAQ:BLFS) At US$19.54?

Does BioLife Solutions (NASDAQ:BLFS) Have A Healthy Balance Sheet?

Mar 12
Does BioLife Solutions (NASDAQ:BLFS) Have A Healthy Balance Sheet?

BioLife Solutions, Inc.'s (NASDAQ:BLFS) Intrinsic Value Is Potentially 64% Above Its Share Price

Feb 19
BioLife Solutions, Inc.'s (NASDAQ:BLFS) Intrinsic Value Is Potentially 64% Above Its Share Price

BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Matching Investor Opinion

Dec 19
BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Matching Investor Opinion

Downgrade: Here's How Analysts See BioLife Solutions, Inc. (NASDAQ:BLFS) Performing In The Near Term

Aug 17
Downgrade: Here's How Analysts See BioLife Solutions, Inc. (NASDAQ:BLFS) Performing In The Near Term

Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load?

Aug 11
Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load?

Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

May 06
Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

Should You Think About Buying BioLife Solutions, Inc. (NASDAQ:BLFS) Now?

Feb 22
Should You Think About Buying BioLife Solutions, Inc. (NASDAQ:BLFS) Now?

Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

Jan 10
Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 20% Undervaluation?

Dec 10
Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 20% Undervaluation?

BioLife: What The Future Holds

Oct 19

BioLife Solutions COO Roderick de Greef to retire

Oct 03

BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

Sep 27
BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

BioLife Solutions GAAP EPS of -$1.71 misses by $1.50, revenue of $40.5M beats by $1.33M

Aug 09

BioLife Solutions: Sell-Side Posture Overly Optimistic, Rate Neutral

Jul 29

Is BioLife Solutions (NASDAQ:BLFS) Using Debt Sensibly?

Jun 15
Is BioLife Solutions (NASDAQ:BLFS) Using Debt Sensibly?

Analyse de la rémunération des PDG

Comment la rémunération de Rod de Greef a-t-elle évolué par rapport aux bénéfices de BioLife Solutions?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

-US$64m

Mar 31 2024n/an/a

-US$62m

Dec 31 2023US$6mUS$199k

-US$66m

Sep 30 2023n/an/a

-US$93m

Jun 30 2023n/an/a

-US$74m

Mar 31 2023n/an/a

-US$141m

Dec 31 2022US$2mUS$450k

-US$140m

Sep 30 2022n/an/a

-US$106m

Jun 30 2022n/an/a

-US$96m

Mar 31 2022n/an/a

-US$15m

Dec 31 2021US$1mUS$412k

-US$9m

Sep 30 2021n/an/a

US$5m

Jun 30 2021n/an/a

US$4m

Mar 31 2021n/an/a

-US$20m

Dec 31 2020US$3mUS$391k

US$2m

Sep 30 2020n/an/a

US$7m

Jun 30 2020n/an/a

US$16m

Mar 31 2020n/an/a

US$39m

Dec 31 2019US$1mUS$403k

-US$2m

Sep 30 2019n/an/a

-US$32m

Jun 30 2019n/an/a

-US$39m

Mar 31 2019n/an/a

-US$44m

Dec 31 2018US$490kUS$350k

-US$25m

Sep 30 2018n/an/a

US$1m

Jun 30 2018n/an/a

-US$146k

Mar 31 2018n/an/a

-US$2m

Dec 31 2017US$520kUS$300k

-US$3m

Rémunération vs marché: La rémunération totale de Rod ($USD 6.39M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 3.30M ).

Rémunération et revenus: La rémunération de Rod a augmenté alors que l'entreprise n'est pas rentable.


PDG

Rod de Greef (64 yo)

less than a year

Titularisation

US$6,387,586

Compensation

Mr. Roderick de Greef, also known as Rod, serves as Director of BioLife Solutions, Inc. since January 03, 2023 and serves as its Chief Executive Officer & Chairman since October 20, 2023. He had been Presi...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Roderick de Greef
CEO & Chairmanless than a yearUS$6.39m0.15%
$ 1.7m
Troy Wichterman
Chief Financial Officer2.8yrsUS$1.70m0.10%
$ 1.2m
Karen Foster
Chief Quality & Operations Officerless than a yearUS$1.12m0.26%
$ 3.0m
Aby Mathew
Chairman of Scientific Advisory Board4.7yrsUS$1.35m0.58%
$ 6.8m
Todd Berard
Chief Marketing Officer9.5yrsUS$734.45k0.24%
$ 2.8m
Sarah Aebersold
Chief Human Resources Officer3.6yrspas de données0.13%
$ 1.6m
Garrie Richardson
Chief Revenue Officerless than a yearpas de données0.26%
$ 3.0m

2.8yrs

Durée moyenne de l'emploi

52yo

Âge moyen

Gestion expérimentée: L'équipe de direction de BLFS est considérée comme expérimentée (ancienneté moyenne 2.8 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Roderick de Greef
CEO & Chairman1.6yrsUS$6.39m0.15%
$ 1.7m
Aby Mathew
Chairman of Scientific Advisory Boardno dataUS$1.35m0.58%
$ 6.8m
Shelly Heimfeld
Member of Scientific Advisory Board17.8yrspas de donnéespas de données
Scott Burger
Member of Scientific Advisory Board16.9yrspas de donnéespas de données
Dayong Gao
Member of Scientific Advisory Board17.8yrspas de donnéespas de données
Andrew Hinson
Member of the Scientific Advisory Boardno dataUS$284.00kpas de données
Erik Woods
Member of Scientific Advisory Board16.9yrspas de donnéespas de données
Lizabeth Cardwell
Member of the Scientific Advisory Boardno datapas de donnéespas de données
Amy DuRoss
Independent Lead Director3.3yrsUS$269.17k0.039%
$ 459.9k
Joydeep Goswami
Independent Director2.8yrsUS$250.00k0.065%
$ 755.1k
Colleen Delaney
Member of Scientific Advisory Board15.8yrspas de donnéespas de données
John McMannis
Member of Scientific Advisory Board12.6yrspas de donnéespas de données

15.8yrs

Durée moyenne de l'emploi

58.5yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration BLFS sont chevronnés et expérimentés (durée moyenne d'administration 15.8 ans).